Overcoming BCRP-mediated resistance involves using BCRP inhibitors or modulators. Agents like elacridar, tariquidar, and Ko143 have shown potential in reversing drug resistance by blocking BCRP function. These inhibitors can enhance the effectiveness of chemotherapeutic agents, providing a promising approach to overcoming MDR in cancer treatment.
